(1 year, 10 months ago)
Commons ChamberWe are determined to reduce any unnecessary bureaucratic barriers that make it harder for our police, and our criminal justice system more broadly, to work as effectively as possible. Although I am not aware of any discussions about the specific issue that my hon. Friend mentions, or about the section 29 exemption for policing under the DPA, I am aware that the Police Federation is doing some work on the issue. If he is willing to write to me with more details, I am very happy to look into the matter further.
(3 years, 1 month ago)
Commons ChamberI am very grateful to the hon. Gentleman. This is what this House does best: raising and highlighting particular cases. I am very happy to meet him to discuss this very challenging case.
(3 years, 4 months ago)
Commons ChamberIn terms of the elective recovery fund, we have worked with the NHS to determine the right thresholds and the right premiums for payment for elective activity over and above what we would be expecting in the circumstances. The NHS is doing an amazing job in difficult circumstances, as the right hon. Gentleman will appreciate, with the impact that infection prevention control restrictions have had on the ability of trusts to see the number of people that they normally would. Trusts are taking huge strides to restore services and the ERF is there to help to ensure that they are funded for that activity level so that they can get provision up and above where it needs to be in order to get the waiting lists down.
We have been clear that the NHS, the price it pays for medicines and the services it provides are off the table in our trade negotiations. No trade agreement has ever affected our ability to keep public services public, nor forced us to pay for more medicines. My Department works closely with the Department for International Trade to ensure that this is reflected in the negotiations of new trade deals.
Last week we proudly celebrated the wonderful creation of the NHS—the most cherished of all national institutions—yet grave fears remain about its ultimate privatisation under this Government. If the Government are determined to sign up to the provisions in the trans-Pacific partnership for investor-state dispute settlement, can the Minister at least do one thing today to limit that damage? Will he guarantee that the NHS will be totally exempt from the scope of those ISDS lawsuits and ensure that that exemption is written into the terms of the UK’s accession?
The Government have been clear in our published approach to negotiations, both on the comprehensive and progressive agreement for trans-Pacific partnership and any US trade deal, that protecting the NHS is a fundamental principle of our trade policy. The UK will ensure that the terms we sign up to in any trade negotiation uphold the Government’s manifesto commitment that the NHS, its services and the cost of medicines are not on the table, and that we hold true to our principles underpinning the NHS—of a service available to all at the point of need, free.